Incaier Sichuan Friendship Hospital, a large-scale Grade III-A general hospital approved by the Health Commission of Sichuan Province (formerly the Sichuan Provincial Commission for Health and Family Planning), integrates medical treatment, teaching, scientific research, prevention, and healthcare, which is affiliated with Incaier, Haier Group's comprehensive health ecosystem brand, and is one of the first privately-run Grade III-A general hospitals in Sichuan Province.
The hospital boasts a floor area of approximately 50,000 square meters, with 600 beds and over 40 clinical and technical departments, including Oncology, General Surgery, Respiratory Medicine, Neurosurgery, and VIP Wards. Among these, the Oncology Department ranks first among private hospitals in Chengdu. We own one provincial-level key specialty, one municipal-level key specialty, and three district-level key specialties, and currently host one national-level key research project, four provincial-level research projects, and 12 municipal-level research projects.
We have attracted top experts from West China Hospital, Sichuan University, which ranks second in China's hospital rankings, including Neurosurgery expert You Chao and Oncology expert Hou Mei, Nephrology expert Peng Wen (postdoctoral fellow from the University of Maryland Kidney Research Center), General Surgery expert Li Ping, Respiratory Medicine expert Xiong Ying, and Cardiovascular Medicine expert Zhou Xingang (visiting scholar at the University of Missouri-Kansas City, and other renowned professors from major hospitals both inside and outside Sichuan Province, forming a well-structured professional team composed of senior, intermediate, and junior professionals, as well as individuals with doctoral, master's, and bachelor's degrees.
We boast a variety of advanced medical devices, such as the United Imaging Ring CT Linear Accelerator uLinac HalosTx, the Accuray TomoTherapy Hi·Art Treatment System (TOMO), the Elekta Precise Pro Dual Photon Electron Linear Accelerator, the MASEP Stereotactic Radiotherapy System (Head Gamma Knife), the Elekta New 3D Afterloader, the Siemens New PET-CT, the United Imaging Tianhe 640 New 320-slice Spiral CT, the United Imaging uMR Omega New 3.0T MRI, the United Imaging uAngio AVIVA New Cardiovascular Imaging System (DSA), the GE-IGS 530 High-end Cardiovascular Imaging System (DSA), the Canon 900i High-end Color Digital Ultrasound Diagnostic System, and the Aesculap Set C4 New 3D Laparoscopic Surgical Treatment System. These devices enable precise localization, planning, and radiotherapy for tumors in all parts of the body.
Multi-disciplinary Team (MDT) approach
Comprehensive treatments including tumor surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, interventional therapy, endocrine therapy, and traditional Chinese medicine.
We have established a rapid, efficient, and widely accessible "Three Centers" (Chest Pain, Stroke, and Trauma) diagnosis and treatment system. Moreover, we have introduced multiple diagnostic models, including 5G remote consultation (MDT consultation), and have built an Internet hospital and smart wards to provide patients with efficient, convenient, and comfortable medical services.
The hospital is a Grade III-A general hospital, which is the highest accreditation level in China's medical institution ranking. Additionally, it serves as a national GCP clinical trial center for drugs and medical devices, a teaching hospital of Chengdu Medical College, a cooperative hospital of Chengdu University of TCM, the Jinjiang District Cancer Prevention and Treatment Center, a "CINV Standardized Management Nausea-Free Demonstration Ward" (Nausea-Free Ward) by the China Anti-Cancer Association, one of the first "Neurosurgery Construction Centers" designated by the National Health Commission, a pilot unit of AAA management center of Sichuan Provincial "National Standardized Cancer Screening Promotion and Management Center", and an "Excellent Provincial and Municipal Tumor Patient Nutrition Guidance Center" by the Chinese Society of Clinical Oncology.
We host multiple large-scale academic conferences annually, continuously enhancing our comprehensive capabilities, and we have engaged in international exchanges with countries and regions including the United States, Australia, South Korea, as well as Morocco, Egypt, India, Pakistan, Vietnam, Laos, Cambodia, Ghana, Sri Lanka, and Nepal.